Effectiveness of Perampanel as the Only Add-on: Retrospective, Multicenter, Observational Real Life Study on epilepsy patients.

Sara GaspariniEdoardo FerlazzoSabrina NeriVittoria CianciAlfonso IudiceFrancesca BisulliPaolo BonanniEmanuele CaggiaAlfredo D'AnielloCarlo Di Bonaventura DiFrancesco Jacopo CosimoElisabetta DominaFedele Dono Antonio Gambardella Carla MariniAlfonso MarrelliSara MatricardiAlessandra MoranoFrancesco PaladinRosaria Renna Pasquale Striano Angelo PascarellaMichele AscoliUmberto Aguglianull null

Published in: Epilepsia open (2022)

this study confirms the good efficacy and safety of PER for focal or generalized epilepsy in real-life conditions. We provide robust data about its effectiveness as only add-on treatment even in patients with a long-standing history of epilepsy and previously treated with many ASMs.

Keyphrases

randomized controlled trial
end stage renal disease
systematic review
cross sectional
newly diagnosed
chronic kidney disease
peritoneal dialysis
machine learning
big data
deep learning
smoking cessation
patient reported